Assessment of dysfunctional tunneled hemodialysis catheters and outcome of endovascular salvage techniques: a simple solution to a complex problem

Objective: The aim of this study was to evaluate the causes of the dysfunctional tunneled cuffed catheters (TCCs) using multi-spiral computed tomography venography (MSCTV), and to analyze the outcomes of endovascular salvage techniques.

Material and methods: This retrospective review data from 27 patients who experienced TCC dysfunction between July 1, 2016 and January 31, 2021 was conducted. Patients’ demographic data, clinical signs and symptoms, and imaging data were collected from interventional radiology database.

Results: MSCTV showed a range of abnormalities in the hemodialysis (HD) patients, including central venous occlusion (n = 4), fibrin sheath formation (n = 3), malposition of the catheter tips (n = 4), central venous perforation (n = 1), thrombus formation (n = 12), regular catheter exchange without determined lesions (n = 3). Interventional catheter salvage procedures were performed, such as catheter exchange, balloon disruption of a fibrin sheath, angioplasty for central vein stenosis, and stent deployment. The technical success rate for catheter insertions was 100%, and no procedure-related severe complications were observed. The 30-day catheter patency for all assessable catheters was 85.2%.

Conclusion: The use of MSCTV showed abnormal findings in almost 88.9% of cases concerning dysfunctional TCC. In this study, the examined appropriate endovascular techniques were found to be safe and technically successful, with a low incidence of procedure-related complications.

Introduction

Functional vascular access is of crucial importance for patients undergoing hemodialysis (HD) (1). Although arteriovenous access is widely acknowledged as preferred option for most HD patients (2, 3), tunneled cuffed catheters (TCCs) remain a vital means of vascular access for a significant number of patients with end-stage renal disease under certain circumstances, such as dialysis requirements of >2–3 weeks, as a “bridge” to renal transplantation or maturation of peritoneal or arteriovenous access, in patients with preexisting failed or complicated arteriovenous access, and in elderly, diabetic and hypertensive patients who have difficulties in arteriovenous access creation and maturation (1, 2). The prevalence of TCCs usage varies from 2% to 49%, depending on geographical region (4). However, the use of catheters carries the highest risk of adverse events, such as infection, mechanical kinking, malpositioning of the catheter tip, thrombus accumulation, growth of a fibrin sheath, and inadequate blood flow, leading to poor dialysis adequacy (4–11). Various medical management protocols have been developed to address these problems, such as flushing the TCC lines with fibrinolysis protocols, reversing the TCC lines, and even TCC exchange (2, 12, 13). However, repeated attempts, which are sometimes performed inappropriately, increase the risk of complications, such as TCC damage or a catheter-related infection (13–15). Therefore, quickly and effectively determining the cause of TCCs dysfunction and guiding clinical treatments is essential for patients with a history of TCCs. In this study, we reported a series of cases in which MSCTV was utilized to evaluate TCC dysfunction and to provide guidance for clinical therapy.

Material and methods

Patients

This retrospective review of the interventional radiology database included patients who underwent radiologically salvage TCCs placement between July 1, 2016 and January 31, 2021. This study enrolled a total of 27 patients (19 female, 8 male) who underwent salvage procedures. The mean age of the patients was 62.89 years (range 32–89 years). Causes of renal failure among the patients were glomerulonephritis (n = 2), systemic lupus erythematosus with renal involvement (n = 2), diabetes mellitus (n = 5), hypertensive nephropathy (n = 6), renal calculus (n = 4), and undetermined causes (n = 8). The indications for TCCs placement included advanced age (n = 8), failed renal transplantation (n = 2), and failed graft or fistula access (n = 17). All patients had a history of prior TCCs insertion, and the reasons for the in-hospital TCC replacement were as follows: catheter dysfunction (n = 15), long-term duration and regular catheter exchange (n = 6), symptomatic extremity and/or facial edema (n = 5), catheter extrusion (n = 1). TCC dysfunction was defined as an inability to maintain adequate extracorporeal blood flow without prolonging the prescribed HD treatment, inability to flush the locking solution from TCC lines, blood flow rate <300 ml/min, arterial pressure <250 mmHg, high venous pressure >250 mmHg, or the need for TCC lines reversal (2, 16, 17). All the lesions were confirmed through MSCTV. The study procedure was conducted in accordance with institutional guidelines, and written informed consent was provided by all patients. All patients were regularly followed up at the nephrology/dialysis clinic in our institution.

MSCTV images

Prior to the endovascular procedure, MSCTV scanning was conducted on each patient using a 256-slice scanner (Aquilion One, Toshiba Co, Tokyo, Japan) from the mandibular plane to the diaphragm plane. To obtain the volume dataset, 80–100 ml non-ionic contrast material (Ultravist 300, 300 mg I/ml, Bayer-Scheming, Leverkusen, Germany) was injected via the contralateral limb using a power injector at the rate of 4 ml per second, followed by normal saline injection. The technique of intelligent trigger was used for MSCTV scanning with the following parameters: 120 kV, 300 mA, 0.5 s, 0.625 mm × 64 mm, and 0.6–0.75 mm reconstruction thickness with an interval of 0.4 mm. Then MSCTV analyses were conducted using three-dimensional workstation software (Vitrea Enterprise Suit Workstation, Vital Images, Inc., Minnesota, USA) by two experienced radiologists. HD was arranged immediately after MSCTV examination and endovascular therapies for remove the contrast agents as soon as possible.

Details of endoluminal procedures

Patient preparation involved the assessment and confirmation of essential hematologic parameters, including platelet count (≥50,000/L), hemoglobin level (≥8 g/dl), and International Normalized Ratio (≤1.5). A pair of fellowship-trained interventionists subsequently performed the endoluminal procedures under sterile conditions and local anesthesia (2% lidocaine). Patients were continuously monitored with electrocardiography and pulse oximetry.

Improper catheter tip placement can be salvaged using a guidewire if the catheter has adhered to contralateral veins. If a tunneled catheter is extruded, catheter exchange is indicated in situ. Fibrin sheath disruption may be appropriate if identified through MSCTV. In cases where the tip of the TCC is confirmed to be in the mediastinum through MSCTV and venography, a covered stent can be used to cover the tear. Symptomatic central thrombosis requires removal of the TCC and consideration of endovascular treatments.

Follow-up

The technical success of the new catheter was defined as having at least one successful session of HD. Patients were followed up to 30 days after TCC exchange.

Results

The demographic characteristics of cases are shown in Table 1. Even though all patients had received anticoagulant treatment and thrombolytic therapy with urokinase, they were unable to resume normal catheter function. MSCTV was successfully utilized in all patients to assess the catheter's shape, tip position, the existence of a thrombus around the catheter or patency problems with the central vein. Out of 27 patients, 4 patients had central venous occlusion (2 in the SVC and 2 in brachiocephalic vein) (Figure 1). Catheter tips or peripheral thrombosis was observed in 12 patients, malpositioning of catheter tips occurred in 4 patients (2 patients with malpositioning in the azygos vein and 2 patients in the contralateral central veins) (Figures 2, 3). Fibrin sheath formation was identified in 3 patients (Figures 4, 5). Additionally, regular catheter exchange occurred without determined lesions in 3 patients, and 1 patient had central venous perforation (Figure 6).

TABLE 1

Table 1. Patients’ characteristics (data are given as number, percentage, range or mean  ±  standard deviation).

FIGURE 1

Figure 1. Recanalization with a bare stent for superior vena cava occlusion due to massive thrombosis. (A,B) CTV in the coronal and sagittal plane showed that the superior vena cava was occluded by massive thrombosis (the blue dotted box) at the catheter tip. (C) Venogram shows SVC occlusion with dilated azygos vein. (D) Recanalization was performed using a 14 mm × 80 mm balloon and a 14 mm × 80 mm bare stent. (E) Repeated angiography showed complete restoration of the blood flow.

FIGURE 2

Figure 2. Endoluminal treatment for the catheter malposition into the azygos vein. (A,B) Transverse CT plain and enhancement scan showed the catheter malposition into the azygos vein. (C,D) Using a guidewire under fluoroscopic control, the catheter was partially withdrawn to the correct position.

FIGURE 3

Figure 3. Endoluminal treatment for the catheter malposition into the contralateral innominate vein. (A–C) CT plain and enhancement scan showed the catheter malposition into the right innominate vein from the left side. (D) Exchanging the catheter under fluoroscopy with a guidewire is performed.

FIGURE 4

Figure 4. Endoluminal Dilation for the fibrin sheath. (A,B) CTV reveals fibrin sheath formation in the axial plane and coronal plane, as the underlying cause of the port malfunction. (C,D) The digital subtracted image: (C) a 10 mm × 60 mm balloon is inserted over a guidewire into the venous lumen of an embedded tunneled dialysis catheter and inflated along the length of the catheter from its distal tip to the cuff. The balloon and the CVC are then removed followed by inserting a new tunneled dialysis (D) over the guidewires and through the initial subcutaneous tract.

FIGURE 5

Figure 5. Endoluminal treatment for the fibrin sheath obstructing the catheter. (A–C) CTV reveals fibrin sheath formation in the axial, coronal, and sagittal planes. (D) When the catheter was withdrawn, the catheter tip appeared stuck to the right lateral sidewall of SVC. The fibrin sheath was stripped with a loop snare created by a 0.18-in guidewire, after which the malfunctional CVC was removed, and a new hemodialysis catheter was advanced.

FIGURE 6

Figure 6. Endoluminal treatment for central venous perforation during dialysis catheter insertion. (A,B) The computed tomography thorax's transverse plane and coronal reformat showed the perforation site outside the right innominate vein (blue arrow). There was no attendant hemo/pneumothorax that otherwise required immediate intervention. (C) The central venogram showed contrast outlining in the mediastinum, confirming the CT findings of catheter perforation of the right innominate vein. (D) A covered stent was subsequently used to cover the rupture when the catheter was pulled into the internal jugular vein. Next, the right subclavian venography showed blood flow smoothly in the stent without contrast extravasation. Then, a new cuff CVC was inserted from the internal jugular vein into the superior vena cava.

Appropriate interventions were given to the patients based on the MSCTV results. In patients with central vein occlusion or massive thrombosis, the catheters were removed. After performing PTA and/or deploying covered stents, a new TCC was inserted. Directly catheters exchange was conducted for cases with a small amount of thrombosis. Endovascular repositioning was performed for 2 patients with malpositioned catheters in the azygos vein, 1 case in central collateral veins, while 1 patient with catheter malpositioned for a long time in central collateral veins was exchanged with a new catheter. Disruption of fibrin sheath was done for the catheters with fibrin sheath formation, and new catheters then replaced the removed ones. Catheters identified with no abnormalities after undergoing MSCTV screening were extracted, as slight intraluminal thrombosis was found near the tips, causing incomplete occlusion. Accordingly, catheter exchange was performed. Anticoagulant therapy was administered to all patients for at least 3 months, and no severe complications were noted during the procedure.

The 30-day catheter patency rate during follow-up was 85.2%. Nonetheless, during the follow-up period, two catheters were extracted due to suspected catheter-related infection and catheter tip malposition.

Discussion

Given their considerable advantages, which include relative stable hemodynamics, immediate use after insertion, pain-free procedure and relatively easy insertion, tunneled cuffed catheters (TCCs) are becoming a preferred option among hemodialysis (HD) patients when no other vascular accesses is available, or when arterio-venous fistula (AVF) is impossible or not suitable for patients with limited life expectancy (2, 18). Consequently, the population of patients receiving TCC as the final HD option requires significant care and attention to sustain its patency (2, 19, 20). The present study showed that, compared to other well-established causes of catheter dysfunctions, such as central venous stenosis, fibrin sheath formation, and thrombus formation, the occurrence of mechanical problems, such as catheter malposition, was relatively low, which is consistent with previous studies (21). Dysfunction immediately noted after TCC placement is usually caused by mechanical problems, such as catheter malposition or venous perforation, which, albeit rare, can lead to an emergency resulting in high mortality rates (11, 22). However, gentle equipment handling and careful fluoroscopic monitoring of the guidewire, dilator, and peel-away sheath placement through Digital Subtraction Angiography (DSA) can avoid this catastrophic event (23). Dysfunction occurring after successful initial use of TCCs is often caused by various factors such as catheter migration, central venous occlusion, central venous thrombosis, and fibrin sheath formation, as reported in the present study. Hence, it is essential to promptly recognize imaging appearances and initiate appropriate immediate action to optimize the outcomes of dysfunctional TCCs.

Chest x-ray is recommended as a routine examination initially to exclude catheter malpositioning or kinking (24). However, it is not enough to evaluate the lumen of catheters and the central veins thoroughly. When x-ray and ultrasound fail to detect abnormalities, DSA is recommended to assess the catheters and the central veins thoroughly (25). However, it is costly and requires a high dose of contrast material, making it more suitable when therapeutic intervention is inevitable. Vascular Doppler sonography is a widely used non-invasive imaging test, both for guiding TCC placement and postoperative assessment. Nonetheless, it has limitations, as images could be confused with those of bones and lungs (26, 27). Due to the limitations of ultrasound in the thoracic cavity, culprit lesion can typically be detected and verified by CT venography, which is noninvasive and enables visualizing all three extremities simultaneously (2, 28). MSCTV has also shown to be effective in assessing catheter-associated venous diseases (29). MSCTV is effectively used in our center as a problem-solving tool in complex cases where conventional imaging techniques have failed to provide sufficient data, including catheter shape, the position of the tip, the presence of thrombus around the catheter, and the patency of central veins.

In HD patients, urgent intervention is necessary in case of TCC dysfunction to prolong the primary vascular access. Surgical intervention can cause significant surgical trauma, and conservative medical treatment fails to effectively solve the problem, especially if fibrin sheath and massive thrombosis occurred. Fibrin sheath is a sleeve of fibrin and proteinaceous material that surrounds the catheter, which affects 40%–100% of TCCs (2). The stuck catheter is always diagnosed at removal time, often leaving operators unprepared. Forceful removal of these catheters can cause severe substernal pain, avulsion of the vena cava, catheter breakage, and potentially fatal vascular lesions. Many techniques described in the literature can be used to treat fibrin sleeves, such as mechanical disruption or replacement and replacing a malfunctioning catheter (30). In our center, we prefer to perform angioplasty/stripping of the fibrin sheath followed by catheter exchange, a method that is also recommended by the KDOQI workgroup (2). Fibrin sheath stripping was found to be less effective than over-the-wire catheter exchange for long-term patency, so this approach was not recommended (31). Catheter survival was reported to be significantly improved by utilization of the sheath disruption technique compared to catheter exchange alone (32). Although the literature on these techniques has shown mixed efficacy, we recommend starting with the least invasive intervention, transcatheter lytic therapy, followed by catheter exchange with balloon disruption of the fibrin sheath or fibrin sheath stripping. However, it is important to avoid excessive pulling to prevent catheter disconnection from the port or catheter fracture. In the present study, we achieved a 100% success rate using this method. Disruption the intravascular fibrin sheath is vital to prevent immediate repeat occlusion by the same fibrin sheath. We achieved this by advanceing the catheter at least 1 cm deeper than its original position. Intraluminal thrombosis is identified as the primary cause of TCC dysfunction (33). While thrombolytic therapy has an excellent initial success rate of over 80%, its 2-month patency can be as low as approximately 36% (34). Endovascular treatments are often the primary treatment option with favorable results (35, 36). The first-line treatment for thrombus-related occlusion in our center is endovascular treatment, which refers to either PTA alone or PTA combined with percutaneous transluminal stenting (35–40). In case of minor catheter tip thrombosis, the catheter can be directly replaced based on anticoagulation. For patients with massive thrombosis and/or venous occlusion, the procedures were carried out as described previously (37). A 0.035-inch stiff guidewire was inserted through the dysfunctional TCCs, and the flossing wire technique was used to recanalize the lesion. Then, PTA and an appropriate covered stent was deployed. Venous injuries occur less frequently than 1% (41), however, appropriate and prompt actions are crucial in the initial management of this potentially fatal complication (11, 42). This complication is partly due to the large caliber of TCCs, which can lead to severe hemorrhage. Although open surgical repair was a conventional treatment for venous perforations (43, 44), endovascular stent repair is an attractive and minimally invasive alternatives (45, 46). In the treatment process, it is important to note that the catheter should only be removed after deploying the covered stent to control the perforation, as demonstrated in our case. Malpositioning is a possible complication that can occur after initial insertion. Repositioning the catheter with a guidewire and exchanging the catheter under fluoroscopy are effective solutions. According to a retrospective study, this meathod had a success rate of 65% at the bedside and 100% under fluoroscopy, which is consistent with our results (47). This problem is particularly noteworthy when there is a prior history of central venous catheter insertion.

Following are some suggestions for the placement of TCCs: firstly, the use of fluoroscopy for placing catheters is strongly recommended, especially for patients with a history of catheterizations. DSA-guided catheterization can monitor the position of the catheter tips in real-time and reduce the chance of vascular injuries. Secondly, when facing the dysfunction of the catheter, if CT is not available, an x-ray examination should be carried out to exclude the malposition of the catheter tip before using urokinase. Thirdly, for patients with multiple catheterizations, fluroscopy should be used to monitor the insertion in real-time or catheter exchange, simultaneously treating vascular diseases. Higher success rates and lower complication rates have been reported for radiologically TCC placement. The 100% technical success rate reported in the present retrospective series further validated the radiologic data for image-guided catheter placement.

There are some limitations in the present study, including the small sample size. Further clinical control study in which MSCTV is being directly compared with DSA is underway to identify the specificity and sensitivity of MSCTV.

Conclusion

MSCTV provides accurate and sufficient information for assessing dysfunctional TCCs. This non-invasive imaging technique provides detailed, high-definition, and three-dimensional reconstruction of the TCC and surrounding structures. Additionally, investigation of patient history helps with planning for the rescue of the catheter and in some instances to help with replacement of the catheter. Interventional placement of TCCs under DSA is a safe and technically successful procedure.

Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

Ethics statement

The study procedure was in accordance with institutional guidelines, and all patients have signed the written informed consent. The patients/participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.

Author contributions

NL was involved in the study design or collection, analysis, and interpretation of data. TX was involved in the data analysis and interpretation paid for a professional editor to assist with writing the manuscript. NZ made considerable contributions to article revision, responding to reviewers and proofreading. All authors contributed to the article and approved the submitted version.

Funding

This work is supported by Project of Guangzhou Municipal Health Bureau, China (20231A011006).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Lawson JH, Niklason LE, Roy-Chaudhury P. Challenges and novel therapies for vascular access in haemodialysis. Nat Rev Nephrol. (2020) 16(10):586–602. doi: 10.1038/s41581-020-0333-2

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, et al. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis. (2020) 75(4 Suppl 2):S1–164.32778223

PubMed Abstract | Google Scholar

3. Allon M. Vascular access for hemodialysis patients: new data should guide decision making. Clin J Am Soc Nephrol. (2019) 14(6):954–61. doi: 10.2215/CJN.00490119

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Pisoni RL, Zepel L, Port FK, Robinson BM. Trends in US vascular access use, patient preferences, and related practices: an update from the US DOPPS practice monitor with international comparisons. Am J Kidney Dis. (2015) 65(6):905–15. doi: 10.1053/j.ajkd.2014.12.014

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Aslam S, Vaida F, Ritter M, Mehta RL. Systematic review and meta-analysis on management of hemodialysis catheter-related bacteremia. J Am Soc Nephrol. (2014) 25(12):2927–41. doi: 10.1681/ASN.2013091009

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Allon M. Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis. (2004) 44(5):779–91. doi: 10.1016/S0272-6386(04)01078-9

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Engstrom BI, Horvath JJ, Stewart JK, Sydnor RH, Miller MJ, Smith TP, et al. Tunneled internal jugular hemodialysis catheters: impact of laterality and tip position on catheter dysfunction and infection rates. J Vasc Interv Radiol. (2013) 24(9):1295–302. doi: 10.1016/j.jvir.2013.05.035

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Al-Ali F, Hamdy AF, Hamad A, Elsayed M, Zafar Iqbal Z, Elsayed A, et al. Safety and efficacy of taurolidine/urokinase vs. taurolidine/heparin as a tunneled catheter lock solution in hemodialysis patients: a prospective, randomized, controlled study. Nephrol Dial Transplant. (2018) 33(4):619–26. doi: 10.1093/ndt/gfx187

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Maldonado-Cárceles AB, García-Medina J, García-Alfonso JJ, Árense-Gonzalo JJ, Torres-Cantero AM. Patency rates of dysfunctional central hemodialysis venous catheter: comparison between catheter exchange alone and catheter exchange with fibrin sheath angioplasty. Diagn Interv Imaging. (2019) 100(3):157–62. doi: 10.1016/j.diii.2018.08.013

CrossRef Full Text | Google Scholar

10. Van Hulle F, Bonkain F, De Clerck D, Aerden D, Vanwijn I, Tielemans C, et al. Efficacy of urokinase lock to treat thrombotic dysfunction of tunneled hemodialysis catheters: a retrospective cohort study. J Vasc Access. (2019) 20(1):60–9. doi: 10.1177/1129729818779549

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Xie P, Peng K, Zhang K, Zhao H, Sheng Y, Tao M, et al. Anatomy revisited: hemodialysis catheter malposition into the chest. Blood Purif. (2019) 47(1–3):58–61. doi: 10.1159/000493177

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Miller LM, MacRae JM, Kiaii M, Clark E, Dipchand C, Kappel J, et al. Hemodialysis tunneled catheter noninfectious complications. Can J Kidney Health Dis. (2016) 3:2054358116669130.28270922

PubMed Abstract | Google Scholar

13. Janne d'Othée B, Tham JC, Sheiman RG. Restoration of patency in failing tunneled hemodialysis catheters: a comparison of catheter exchange, exchange and balloon disruption of the fibrin sheath, and femoral stripping. J Vasc Interv Radiol. (2006) 17(6):1011–5. doi: 10.1097/01.RVI.0000223692.99800.2E

CrossRef Full Text | Google Scholar

14. Svoboda P, Barton RP, Barbarash OL, Butylin AA, Jacobs BR, Lata J, et al. Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial. Crit Care Med. (2004) 32(10):1990–6. doi: 10.1097/01.CCM.0000142706.01717.EB

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Abdelmoneim AS, Miller LM, Armstrong S, Sood MM, Wazny L, Chateau D, et al. Use of an alteplase algorithm for the management of hemodialysis catheter dysfunction. Hemodial Int. (2012) 16(2):298–305. doi: 10.1111/j.1542-4758.2011.00609.x

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Porazko T, Hobot J, Klinger M. Non-invasive tunnelled catheter reposition (NTCR): a simple and safe method to restore central tunnelled catheter function for haemodialysis. Sci Rep. (2020) 10(1):8162. doi: 10.1038/s41598-020-64985-3

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Wang P, Wang Y, Qiao Y, Zhou S, Liang X, Liu Z. A retrospective study of preferable alternative route to right internal jugular vein for placing tunneled dialysis catheters: right external jugular vein versus left internal jugular vein. PLoS One. (2016) 11(1):e0146411. doi: 10.1371/journal.pone.0146411

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Saran R, Li Y, Robinson B, et al. US renal data system 2015 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. (2016) 67(3 Suppl 1): Svii; S1–305.26925525

PubMed Abstract | Google Scholar

19. Ravani P, Quinn R, Oliver M, Robinson B, Pisoni R, Pannu N, et al. Examining the association between hemodialysis access type and mortality: the role of access complications. Clin J Am Soc Nephrol. (2017) 12(6):955–64. doi: 10.2215/CJN.12181116

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Hemmelgarn BR, Moist LM, Lok CE, Tonelli M, Manns BJ, Holden RM, et al. Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. N Engl J Med. (2011) 364(4):303–12. doi: 10.1056/NEJMoa1011376

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Suh PS, Park SY, Kim J, Chang KO, Won JH. Assessment of venographic abnormalities during replacement of dysfunctional tunneled hemodialysis catheters and outcome of endovascular salvage techniques. J Korean Soc Radiol. (2018) 79(3):152. doi: 10.3348/jksr.2018.79.3.152

CrossRef Full Text | Google Scholar

22. Burak Çildağ M, Faruk Kutsi Köseoğlu Ö. Esophageal perforation during cuffed tunneled catheter introduction: first case in literature. Hemodial Int. (2016) 20(4):E1–3. doi: 10.1111/hdi.12416

CrossRef Full Text | Google Scholar

23. Bhutta ST, Culp WC. Evaluation and management of central venous access complications. Tech Vasc Interv Radiol. (2011) 14(4):217–24. doi: 10.1053/j.tvir.2011.05.003

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Gouda ZE, Emara MM, Elbarbary HS, Koura MAA, Elarbagy AR. Studying alternative approaches for placement of cuffed hemodialysis catheters in hemodialysis patients with bilateral internal jugular vein occlusion. J Vasc Access. (2019) 20(3):250–9. doi: 10.1177/1129729818794414

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Teichgräber UK, Gebauer B, Benter T, Wagner HJ. Central venous access catheters: radiological management of complications. Cardiovasc Intervent Radiol. (2003) 26(4):321–33.

Google Scholar

26. Millington SJ, Colvin MO, Shiloh AL, Koenig S. How I do it: ultrasound-guided internal jugular and femoral central venous catheter insertion. Chest. (2020) 158(6):2425–30. doi: 10.1016/j.chest.2020.06.026

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Bajaj J, Khan MS. Ultrasound to the rescue: management of looped guidewire during hemodialysis catheter insertion in the left internal jugular vein. J Med Ultrasound. (2021) 29(3):209–11.34729332

PubMed Abstract | Google Scholar

28. Murphy EA, Ross RA, Jones RG, et al. Imaging in vascular access. Cardiovasc Eng Technol. (2017) 8(3):255–72. doi: 10.1007/s13239-017-0317-y

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Lichtenstein T, Mammadov K, Rau K, Große Hokamp N, Do TD, Maintz D, et al. Long-term follow-up and clinical relevance of incidental findings of fibrin sheath and thrombosis on computed tomography scans of cancer patients with port catheters. Ther Clin Risk Manag. (2021) 17:111–8. doi: 10.2147/TCRM.S287544

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Kennard AL, Walters GD, Jiang SH, Talaulikar GS. Interventions for treating central venous haemodialysis catheter malfunction. Cochrane Database Syst Rev. (2017) 10(10):Cd011953.29106711

PubMed Abstract | Google Scholar

31. Merport M, Murphy TP, Egglin TK, Dubel GJ. Fibrin sheath stripping versus catheter exchange for the treatment of failed tunneled hemodialysis catheters: randomized clinical trial. J Vasc Interv Radiol. (2000) 11(9):1115–20. doi: 10.1016/S1051-0443(07)61351-7

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Oliver MJ, Mendelssohn DC, Quinn RR, et al. Catheter patency and function after catheter sheath disruption: a pilot study. Clin J Am Soc Nephrol. (2007) 2(6):1201–6. doi: 10.2215/CJN.01910507

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Citla Sridhar D, Abou-Ismail MY, Ahuja SP. Central venous catheter-related thrombosis in children and adults. Thromb Res. (2020) 187:103–12. doi: 10.1016/j.thromres.2020.01.017

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Savader SJ, Ehrman KO, Porter DJ, Haikal LC, Oteham AC. Treatment of hemodialysis catheter-associated fibrin sheaths by rt-PA infusion: critical analysis of 124 procedures. J Vasc Interv Radiol. (2001) 12(6):711–5. doi: 10.1016/S1051-0443(07)61441-9

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Horikawa M, Quencer KB. Central venous interventions. Tech Vasc Interv Radiol. (2017) 20(1):48–57. doi: 10.1053/j.tvir.2016.11.006

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Kundu S. Review of central venous disease in hemodialysis patients. J Vasc Interv Radiol. (2010) 21(7):963–8. doi: 10.1016/j.jvir.2010.01.044

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Li N, Zeng N, Chen B, Huang Y. Endovascular treatments of tunneled central venous catheter-induced superior vena cava complete occlusion via through-and-through technique. Hemodial Int. (2021) 25(1):35–42. doi: 10.1111/hdi.12889

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Chen B, Lin R, Dai H, Li N, Tang K, Yang J, et al. Sharp recanalization for treatment of central venous occlusive disease in hemodialysis patients. J Vasc Surg Venous Lymphat Disord. (2022) 10(2):306–12. doi: 10.1016/j.jvsv.2021.08.007

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Huang Y, Chen B, Tan G, Cheng G, Zhang Y, Li J, et al. The feasibility and safety of a through-and-through wire technique for central venous occlusion in dialysis patients. BMC Cardiovasc Disord. (2016) 16(1):250. doi: 10.1186/s12872-016-0411-3

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Horita Y. Percutaneous transluminal angioplasty for central venous stenosis or occlusion in hemodialysis patients. J Vasc Access. (2019) 20(1_suppl):87–92. doi: 10.1177/1129729817747545

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Vats HS. Complications of catheters: tunneled and nontunneled. Adv Chronic Kidney Dis. (2012) 19(3):188–94. doi: 10.1053/j.ackd.2012.04.004

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Pua U. Central vein perforation during tunneled dialysis catheter insertion: principles of acute management. Hemodial Int. (2014) 18(4):838–41. doi: 10.1111/hdi.12179

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Sainaresh VV, Jain SH, Patel HV, Shruti G, Trivedi HL. Malplacement of hemodialysis permcatheter into anterior mediastinum following innominate vein perforation. Semin Dial. (2012) 25(1):95–6. doi: 10.1111/j.1525-139X.2011.00950.x

PubMed Abstract | CrossRef Full Text | Google Scholar

44. Florescu MC, Mousa A, Salifu M, Friedman EA. Accidental extravascular insertion of a subclavian hemodialysis catheter is signaled by nonvisualization of catheter tip. Hemodial Int. (2005) 9(4):341–3. doi: 10.1111/j.1492-7535.2005.01151.x

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Anaya-Ayala JE, Charlton-Ouw KM, Kaiser CL, Peden EK. Successful emergency endovascular treatment for superior vena cava injury. Ann Vasc Surg. (2009) 23(1):139–41. doi: 10.1016/j.avsg.2008.02.016

PubMed Abstract | CrossRef Full Text | Google Scholar

46. Li N, Huang YH. Delayed pericardial tamponade following central venous recanalization. J Vasc Access. (2021) 22(6):979–83. doi: 10.1177/1129729820938177

PubMed Abstract | CrossRef Full Text | Google Scholar

47. Trerotola SO, Thompson S, Chittams J, Vierregger KS. Analysis of tip malposition and correction in peripherally inserted central catheters placed at bedside by a dedicated nursing team. J Vasc Interv Radiol. (2007) 18(4):513–8. doi: 10.1016/j.jvir.2007.01.020

PubMed Abstract | CrossRef Full Text | Google Scholar